Rx only. Indicated for pediatric ADHD monotherapy, ages 7 to 12.Important Safety InformationInstructions for UseQuick Start Guide
Monarch eTNS® Systemby NeuroSigma

The first FDA-cleared, drug-free therapy for pediatric ADHD.

Gentle overnight trigeminal nerve stimulation that helps improve attention and behavior in children ages 7 to 12 who are not taking ADHD medication.¹ ²

Get MonarchSee the science
A smiling boy with a backpack outside his school, his parents standing behind him

I am a...

Parent or CaregiverHow Monarch works at home, what it costs, and how to get it, including a $50 online evaluation.For families →Health Care ProviderClinical results, ease of use, and how to download the Physician Info Kit and Prescription Form.For clinicians →
FDA-clearedFirst drug-free therapy for pediatric ADHD
Ages 7 to 12Used on its own, without ADHD medication
OvernightAbout 8 hours of gentle stimulation during sleep
Developed at UCLAStudied in NIH-funded clinical trials
A child sleeping peacefully in bed with the Monarch device resting on the pillow

How it works

Therapy that happens while your child sleeps

A soft patch on the forehead connects to the small Monarch device. Gentle pulses stimulate the trigeminal nerve for about 8 hours overnight. Nothing to swallow and nothing to take to school.

  1. Bedtime: apply the patch and turn the device on.
  2. Overnight: your child sleeps through a mild tingling.
  3. Morning: remove the patch and start the day.
Learn more for families

No prescriber yet?

Get evaluated online by a licensed clinician

A $50 telehealth evaluation from home. If you go ahead with Monarch, the $50 is credited toward your purchase.

Telehealth evaluation — coming soon

Important Safety Information

Indication: Monarch eTNS® System is indicated for treatment of pediatric ADHD as a monotherapy in patients ages 7 to 12 who are not currently on prescription ADHD medications. The device is for use during sleep under the supervision of a caregiver.

Contraindications: Not for use in patients with implanted pacemakers, neurostimulators, or metallic/electronic head implants. Do not use in children under 7.

Common side effects: Drowsiness, increased appetite, insomnia, teeth clenching, headache, fatigue. Rx only.

For full Indication, Contraindications and Important Safety Information, see the Instructions for Use or contact Medical Affairs at 310-479-3100.

References1. McGough JJ, Loo SK, Sturm A, et al. An eight-week, open-label pilot feasibility study of trigeminal nerve stimulation in youth with attention-deficit/hyperactivity disorder. Brain Stimulation. 2015;8:299-304.2. McGough JJ, Sturm A, Cowen J, et al. Double-blind, sham-controlled, pilot study of trigeminal nerve stimulation for attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2019;58(4):403-411.